BISOLVON

This brand name is authorized in Austria, Brazil, Croatia, Ecuador, Finland, France, Germany, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, South Africa, UK.

Active ingredients

The drug BISOLVON contains one active pharmaceutical ingredient (API):

1	Bromhexine UNII YC2ZOM3Z8V - BROMHEXINE HYDROCHLORIDE
	Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”.
	Read more about Bromhexine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BISOLVON Oral solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CB02	Bromhexine	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720050070817, 576720050070917, 576720050071017
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00139011, 07706855
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4383-MEE-0918, 4481-MEE-1118, 4528-MEE-0119
FI	Lääkealan turvallisuus- ja kehittämiskeskus	034367, 045051, 112976, 420976
FR	Base de données publique des médicaments	61360073
GB	Medicines & Healthcare Products Regulatory Agency	246171
HR	Agencija za lijekove i medicinske proizvode	HR-H-025912186, HR-H-042974735, HR-H-667277868
IE	Health Products Regulatory Authority	15328
JP	医薬品医療機器総合機構	2234001F1312, 2234400A1062, 2234700G1051
MT	Medicines Authority	MA1470/00101, PI1438/04401A, PI908/05701A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	73688, 78884
NL	Z-Index G-Standaard	12357782, 12515140, 13529919, 14049430
NL	Z-Index G-Standaard, PRK	1325, 16810, 17922, 46108
NZ	Medicines and Medical Devices Safety Authority	491, 493
ZA	Health Products Regulatory Authority	C/10.1/66